Article

April 5, 2013

Yelena Yankovskaya, PharmD, Discusses the Expectations and Roles of VBID in Combating Nonadherence

Yelena Yankovskaya, PharmD, a managed markets fellow at the Mayes College of Healthcare Business and Policy, describes the expectations and roles of predictive modeling, value-based insurance design, and gamification/social media in contemporary managed care pharmacy.

Yelena Yankovskaya, PharmD, a managed markets fellow at the Mayes College of Healthcare Business and Policy, describes the expectations and roles of predictive modeling, value-based insurance design, and gamification/social media in contemporary managed care pharmacy.

This video was taken at the Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo in San Diego, CA, on April 4, 2013.

Related Videos

Milind Desai, MD

Masanori Aikawa, MD

Neil Goldfarb, GPBCH

Mabel Mardones, MD.

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah.

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester

Screenshot of Susan Wescott, RPh, MBA

Screenshot of an interview with Adam Colborn, JD

Screenshot of an interview with James Chambers, PhD

Screenshot of an interview with Megan Ehret, PharmD

Related Content

Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com

November 21st 2024

Semaglutide Eligibility Expands to Over Half of US Adults

Cameron Santoro

Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.

August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.

Blood test | Image: Edward Jenner for Pexels

November 18th 2024

KRAKEN: Oral Muvalaplin Safely Lowers Lp(a) in Early-Stage Trial

Results bring more competition to treat this genetically driven target for cardiovascular risk.

Managed Care Cast.

June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia

On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.

Entresto packaging | Image credit: Novartis

November 18th 2024

Cardiomyopathy Risk Plummets When Sacubitril/Valsartan Taken With Chemo

The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse events in patients less at risk of cardiomyopathy.

Kerendia press photo | Image credit: Bayer

November 18th 2024

Benefits of Finerenone Similar in Women and Men, Analysis Finds

Follow-up results for the FINEARTS-HF trial focused on specific results for women and men, hyperkalemia risk, and an analysis of the elements of its composite end point.

Related Content

Semaglutide injectors. | Image Credit :Andreas Prott- stock.adobe.com

November 21st 2024

Semaglutide Eligibility Expands to Over Half of US Adults

Cameron Santoro

Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.

August 29th 2023

The Importance of Examining and Preventing Atrial Fibrillation

At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.

Blood test | Image: Edward Jenner for Pexels

November 18th 2024

KRAKEN: Oral Muvalaplin Safely Lowers Lp(a) in Early-Stage Trial

Results bring more competition to treat this genetically driven target for cardiovascular risk.

Managed Care Cast.

June 28th 2022

Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions

Matthew Gavidia

On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.

Entresto packaging | Image credit: Novartis

November 18th 2024

Cardiomyopathy Risk Plummets When Sacubitril/Valsartan Taken With Chemo

The SARAH trial was limited to high-risk patients, which the lead investigator said prevented unnecessary exposure to adverse events in patients less at risk of cardiomyopathy.

Kerendia press photo | Image credit: Bayer

November 18th 2024

Benefits of Finerenone Similar in Women and Men, Analysis Finds

Follow-up results for the FINEARTS-HF trial focused on specific results for women and men, hyperkalemia risk, and an analysis of the elements of its composite end point.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions